<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d63">
    <sentence id="DDI-MedLine.d63.s0" text="Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.&#xd;&#xa;">
        <entity id="DDI-MedLine.d63.s0.e0" charOffset="36-43"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s0.e1" charOffset="111-124"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s0.e2" charOffset="130-137"
            type="drug" text="morphine"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s1" text="In the present study, it is proposed that the opioids applied to supraspinal brain sites produced their analgesic effects by the activation of different descending pain inhibitory systems. ">
        <entity id="DDI-MedLine.d63.s1.e0" charOffset="46-52"
            type="group" text="opioids"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s2" text="The blockade of the spinal endorphinergic system by intrathecal naloxone on the production of tail-flick inhibition induced by intraventricular beta-endorphin and morphine was then studied. ">
        <entity id="DDI-MedLine.d63.s2.e0" charOffset="64-71"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s2.e1" charOffset="144-157"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s2.e2" charOffset="163-170"
            type="drug" text="morphine"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s3" text="Intraventricular injection of beta-endorphin and morphine produced an inhibition of the tail-flick response to the heat stimulus in rats. ">
        <entity id="DDI-MedLine.d63.s3.e0" charOffset="30-43"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s3.e1" charOffset="49-56"
            type="drug" text="morphine"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s4" text="Intrathecal injection of naloxone at doses of 0.4 to 40 micrograms caused a dose-related blockade of the inhibition of the tail-flick response induced by intraventricular injection of beta-endorphin, and a high dose of naloxone (40 micrograms) completely blocked the tail-flick inhibition induced by intraventricular beta-endorphin (16 micrograms). ">
        <entity id="DDI-MedLine.d63.s4.e0" charOffset="25-32"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s4.e1" charOffset="184-197"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s4.e2" charOffset="219-226"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s4.e3" charOffset="317-330"
            type="drug_n" text="beta-endorphin"/>
        <ddi id="DDI-MedLine.d63.s4.d0" e1="DDI-MedLine.d63.s4.e0"
            e2="DDI-MedLine.d63.s4.e1" type="effect"/>
        <ddi id="DDI-MedLine.d63.s4.d1" e1="DDI-MedLine.d63.s4.e2"
            e2="DDI-MedLine.d63.s4.e3" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s5" text="On the other hand, intrathecal naloxone (12-120 micrograms) had only a very weak effect on the tail-flick inhibition induced by intraventricular morphine (40 micrograms). ">
        <entity id="DDI-MedLine.d63.s5.e0" charOffset="31-38"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s5.e1" charOffset="145-152"
            type="drug" text="morphine"/>
        <ddi id="DDI-MedLine.d63.s5.d0" e1="DDI-MedLine.d63.s5.e0"
            e2="DDI-MedLine.d63.s5.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s6" text="Intraventricular injection of naloxone at doses of 1.2 to 12 micrograms equally antagonized in a dose-dependent manner the tail-flick inhibition induced by intraventricular beta-endorphin and morphine. ">
        <entity id="DDI-MedLine.d63.s6.e0" charOffset="30-37"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s6.e1" charOffset="173-186"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s6.e2" charOffset="192-199"
            type="drug" text="morphine"/>
        <ddi id="DDI-MedLine.d63.s6.d0" e1="DDI-MedLine.d63.s6.e0"
            e2="DDI-MedLine.d63.s6.e1" type="effect"/>
        <ddi id="DDI-MedLine.d63.s6.d1" e1="DDI-MedLine.d63.s6.e0"
            e2="DDI-MedLine.d63.s6.e2" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s7" text="The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; ">
        <entity id="DDI-MedLine.d63.s7.e0" charOffset="35-42"
            type="drug" text="naloxone"/>
        <entity id="DDI-MedLine.d63.s7.e1" charOffset="109-122"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s7.e2" charOffset="132-139"
            type="drug" text="morphine"/>
        <entity id="DDI-MedLine.d63.s7.e3" charOffset="206-219"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s7.e4" charOffset="225-232"
            type="drug" text="morphine"/>
    </sentence>
    <sentence id="DDI-MedLine.d63.s8" text="descending epsilon and mu systems for beta-endorphin and morphine, respectively, are proposed.">
        <entity id="DDI-MedLine.d63.s8.e0" charOffset="38-51"
            type="drug_n" text="beta-endorphin"/>
        <entity id="DDI-MedLine.d63.s8.e1" charOffset="57-64"
            type="drug" text="morphine"/>
    </sentence>
</document>
